Jaeseung Lim

Chief Executive Officer & Chief Scientific Officer • Cellatz Therapeutics


  • Post-Doctorial Fellow, OB/GY, Stanford University
  • Ph.D, Biochemistry & Molecular Biology, University of Leeds (UK)
  • MSc, Biochemistry, Chemistry Dept., Seoul National University
  • BS, Chemistry Dept., Seoul National University


  • Adjunctive Professor, Sookmyung Woman’s University
  • CEO & CSO, Cellatoz Therapeutics, Inc. (Korea)
  • CSO/Senior VP, CHA Biotech (Korea)
  • EVP, NexBio Corp. (Korea)
  • Co-founder & BoD memeber, MediCell Inc. (Korea, w/ KRIBB)
  • BoD member, Head of R&D, InnoCell Inc. (Korea)

Also Speaking

James Kusena

Vice President, Bioprocessing & Applications • MicrofluidX

Kristin Viswanathan Wolff

Vice President, Market Access  • bluebird bio

Judith Koliwer

PhD Principal Consultant, Cell & Gene Therapy  • Körber Pharma Software

Also Speaking


Post-Event Report

Download the post-event report for Advanced Therapies Week 2023.

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.